Here are five picks in a sector whose private- and public-sector support is sure to continue as Asia ages.
The charts are generally bullish and HCA could head up towards $200, but there are some caveats.
The shares have doubled from their March nadir.
My preference here is to target an option that will work more like a stock replacement approach.
A look at the fast-growing field of telehealth, both for people and, as a less-well known market, for pets.
A drugstore giant, a maker of office technology, a chicken producer and a shoe seller make up one-third of the 2021 Tax Loss Selling Recovery Portfolio.
Here's where I'd consider taking profits.
Governments around the world have committed to buying hundreds of millions of doses of AZD1222.
The battle to gain control over Covid-19 is entering a crucial stage and calls for continued determination.
Here's our analysis and trading strategy for CNC shares.